• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 5. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Oligosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Oligosaccharides

Exploring Lewis X Trisaccharide, Methyl Glycoside (CAS No. 176106-81-3): Structure, Applications, and Research Insights

The Lewis X Trisaccharide, Methyl Glycoside (CAS No. 176106-81-3) is a synthetic carbohydrate derivative that has garnered significant attention in glycobiology and biomedical research. This compound, characterized by its trisaccharide structure and methyl glycoside modification, serves as a critical tool for studying cell-surface interactions, immune responses, and glycosylation patterns. Its unique chemical properties make it invaluable for applications ranging from diagnostic development to drug discovery.

Structurally, Lewis X Trisaccharide belongs to the fucosylated oligosaccharides family, featuring a terminal galactose residue linked to N-acetylglucosamine and fucose. The methyl glycoside moiety enhances its stability, facilitating its use in bioconjugation and glycan microarray technologies. Researchers leverage this compound to mimic natural glycan epitopes, enabling studies on pathogen-host interactions and cancer biomarkers—topics currently dominating scientific literature and search engine queries like "role of glycans in cancer" or "carbohydrate-based therapeutics."

In the context of biopharmaceuticals, Lewis X Trisaccharide, Methyl Glycoside is pivotal for designing glycoconjugate vaccines. Its ability to elicit immune responses aligns with the growing demand for next-generation vaccines, a hotspot underscored by the COVID-19 pandemic. Searches for "glycan vaccine adjuvants" or "synthetic carbohydrates in immunotherapy" highlight its relevance. Additionally, its role in stem cell research—particularly in cell adhesion and differentiation—resonates with trends in regenerative medicine.

From a technical perspective, the compound's CAS No. 176106-81-3 ensures precise identification in chemical databases and regulatory filings. Its synthesis involves advanced glycosylation techniques, a topic frequently searched by organic chemists ("stereoselective glycosylation methods"). The methyl glycoside derivative also simplifies NMR analysis, addressing common challenges in carbohydrate characterization.

Beyond academia, industries utilize Lewis X Trisaccharide in diagnostic kits for detecting autoimmune diseases and infections. Its compatibility with surface plasmon resonance (SPR) and mass spectrometry aligns with the rise of precision diagnostics. Queries like "glycan biomarkers for early disease detection" reflect this intersection of glycobiology and clinical innovation.

Environmental and scalability considerations further elevate its profile. Unlike natural extracts, synthetic Lewis X Trisaccharide, Methyl Glycoside offers batch-to-batch consistency—a key concern for Good Manufacturing Practice (GMP) compliance. This aligns with searches on "sustainable glycochemical production" and "scalable oligosaccharide synthesis."

In summary, Lewis X Trisaccharide, Methyl Glycoside (CAS No. 176106-81-3) bridges fundamental research and translational applications. Its multifaceted roles in immunology, drug development, and diagnostics position it at the forefront of glycoscience—a field increasingly explored via AI-driven literature mining and high-throughput screening. As interest in glycan-based therapeutics grows, this compound will remain a cornerstone for both discovery and industrial innovation.

• 120864-60-0(D-Glucose, O-6-deoxy-a-L-galactopyranosyl-(1®2)-O-b-D-galactopyranosyl-(1®3)-O-[6-deoxy-a-L-galactopyranosyl-(1®4)]-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-O-[6-deoxy-a-L-galactopyranosyl-(1®3)]-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1®3)-O-b-D-galactopyranosyl-(1®4)-)
• 1398-61-4(Chitin, Practical Grade)
• 83512-85-0(Carboxymethyl chitosan)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)